SERI® Surgical Scaffold facilitates native tissue generation over time1

As seen in a full-scale animal model study, SERI® Surgical Scaffold and newly generated tissue demonstrated thickness at 3 months.1

In the same study,

native tissue contributed approximately twice the starting thickness of the scaffold alone at 24 months.1

At this point, most of SERI® Surgical Scaffold has been bioreplaced with native, well-vascularized tissue—meaning the resulting thickness comes almost entirely from the newly generated tissue.1


Methodology: In an ovine subcutaneous thoracic wall implant study designed to measure the strength and thickness of SERI® Surgical Scaffold and newly generated native tissue at up to 24 months after implantation of SERI®.1
Note: Similar studies in humans have not been performed.


Bioreplaced
Over Time1,*
Learn more
Favorable
Biocompatibility1,*
Learn how our silk
is different
Support and Strength
from Native Tissue1,*
Learn more
Case
Reviews
See operative
techniques using SERI®

Indications for Use
SERI® Surgical Scaffold is indicated for use as a transitory scaffold for soft tissue support and repair to reinforce deficiencies where weakness or voids exist that require the addition of material to obtain the desired surgical outcome. This includes reinforcement of soft tissue in plastic and reconstructive surgery, and general soft tissue reconstruction.

Important Safety Information

Contraindications

  • Patients with a known allergy to silk
  • Contraindicated for direct contact with bowel or viscera where formation of adhesions may occur

Warnings

  • SERI® Surgical Scaffold must be placed in maximum possible contact with healthy well-vascularized tissue to encourage ingrowth and tissue remodeling
  • Caution should be used when implanting SERI® Surgical Scaffold in pregnant women. The use of a device that can impede tissue expansion may be hazardous during pregnancy

Adverse Reactions
Adverse reactions are those typically associated with surgically implantable materials, including infection, inflammation, adhesion formation, fistula formation, and extrusion.

Important
Before using SERI® Surgical Scaffold, read the Instructions for Use which accompany the product for full safety information. This can be found here.

Caution
Rx only.

*Methodology: In an ovine subcutaneous thoracic wall implant study designed to measure the strength and thickness of SERI® Surgical Scaffold and newly generated native tissue at up to 24 months after implantation of SERI®.1
Note: Similar studies in humans have not been performed.

†Methodology: In a study using SERI® Surgical Scaffold in a rat model of abdominal wall defect.1
Note: Similar studies in humans have not been performed.


Instructions for Use   |   Privacy Statement   |  

Terms of Use |   Terms of Sale     |  

Sofregen.com     |  

Contact Sofregen   |  

Site Map   |   References

©Sofregen Medical Inc., 200 Boston Ave, Suite 1100, Medford MA 02155 ® marks owned by Sofregen Medical Ireland LTD
  L-504 10.27.17